Home › Funds › Marshall Wace › PHVS
Marshall Wace position in PHVS
PHARVARIS N V · Health Care
Latest position (Q4 2025)31.83K sh
Reported value held$883.34K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 60.12K | $1.69M | New |
| Q1 2024 | 58.17K | $1.34M | Reduce |
| Q2 2024 | 51.17K | $961.96K | Reduce |
| Q3 2024 | 59.01K | $1.09M | Add |
| Q3 2025 | 27.10K | $676.05K | New |
| Q4 2025 | 31.83K | $883.34K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PHVS
- Fidelity Management & Research (FMR) 6.57M sh · $227.03M · Q2 2026
- Viking Global Investors 3.65M sh · $126.33M · Q2 2026
- Wellington Management Group 2.39M sh · $82.75M · Q2 2026
- Point72 Asset Management 1.64M sh · $56.75M · Q2 2026
- BlackRock Inc 771.45K sh · $26.68M · Q2 2026
- Balyasny Asset Management 524.30K sh · $18.13M · Q2 2026
- D. E. Shaw & Co 471.40K sh · $16.30M · Q2 2026
- Millennium Management 427.40K sh · $14.78M · Q2 2026
- UBS Group AG 254.79K sh · $8.81M · Q2 2026
- Citadel Advisors 250.38K sh · $8.66M · Q2 2026
- Two Sigma Investments 216.64K sh · $7.49M · Q2 2026
- Goldman Sachs Group 149.98K sh · $5.19M · Q2 2026